Merck & Co.
Merck & Co. is the world’s seventh largest pharmaceutical company by market capitalization and revenue. Its headquarters is located in Kenilworth, New Jersey. The Merck Manuals, a series of medical reference books for physicians, nurses, technicians, and veterinarians, is the company’s best-selling medical reference. Merck Sharp & Dohme outside the United States and Canada, is a subsidiary of Merck.
About Merck & Co. in brief
Merck & Co. is the world’s seventh largest pharmaceutical company by market capitalization and revenue. Its headquarters is located in Kenilworth, New Jersey. The company ranked No. 78 in the 2018 Fortune 500 list of the largest United States corporations by total revenue. The Merck Manuals, a series of medical reference books for physicians, nurses, technicians, and veterinarians, is the company’s best-selling medical reference. Merck Sharp & Dohme outside the United States and Canada, is a subsidiary of Merck. The original Merck based in Darmstadt, Germany, was founded in 1668 by the Merck family and introduced the commercial manufacture of morphine. In 1929, H. K. Mulford Company merged with Sharp and DohMe, Inc. and brought vaccine technology, including immunization of cavalry horses in World War I and delivery of a diphtheria antitoxin to Merck and Co. In 1965 Merck & Company. acquired Charles E. Frosst Ltd. of Montreal, Quebec, Canada and created Merck-Frosst Canada, Inc, as its Canadian subsidiary and pharmaceutical research facility. It has been incorporated in New Jersey since 1970. In 2009, Merck announced that it would merge with competitor Schering-Plough in a deal worth $41 billion. In November 1993 Merck completed a USD 6 billion purchase of Medco Containment Services Inc, which was spun off ten years later as Merck Medco Medco. In July 2010, the company was renamed Merck Canada, and the company closed in July 2010.
It was originally formed as a joint venture with AstraZenecas and DuPonts and established joint ventures with Johnson & Johnson to sell over-the-counter consumer medications. In the late 1980s, the. company also established a joint ventures. with DuPont to sell consumer medications to Johnson and Johnson. In 2012, the two companies announced that they would merge in a $41.41 billion deal. The deal was announced in November 2009, and was later completed in November 2010. The merged company was called Merck&Plough. The combined company kept the trade name Merck in the U.S. and Canada. It also kept the name Merk Sharp &Dohme outside North America. In 2013, the merged company announced it would. merge with competitors Schering &Plough, a competitor of Schering, in a US$41 billion buyout deal. It is now known as Merck Med co. The merger was completed in December 2013 and the new company was incorporated in July 2014. The new company is based in New York City and has a headquarters in the city’s SoHo neighborhood. In March 2014, the firm announced it will be based in Newark, New York, and it will have a second headquarters in Newark in the spring of 2015. In April 2015, it announced it was expanding into the UK with a second facility in London. In May 2015, the new Merck HQ was opened in London, England.
You want to know more about Merck & Co.?
This page is based on the article Merck & Co. published in Wikipedia (as of Nov. 30, 2020) and was automatically summarized using artificial intelligence.
